Modiodal (Modafinil)

Modafinil enhances alertness by blocking the reuptake of dopamine, leading to higher dopamine levels in the brain. It also activates orexin neurons and stimulates histamine and norepinephrine pathways, collectively increasing cortical arousal and reducing the drive to sleep.

The appropriate dose of Modiodal is determined by a qualified prescriber based on the patient’s medical condition, response to therapy, and individual tolerability. Dosage may be adjusted over time, and patients should follow the prescribing clinician’s instructions.

Safety data for modafinil in pregnancy and lactation are limited. The drug is classified as having an unknown risk, so clinicians must weigh potential benefits against possible risks to the fetus or infant. Women who are pregnant, planning pregnancy, or breastfeeding should discuss alternatives with their healthcare provider.

To request Modiodal, submit an enquiry on the product page at gnhindia.com, specifying the required quantity. GNH India works with hospitals, pharmacies, and procurement teams worldwide, verifies trade or institutional credentials, and then provides pricing, availability, shipping details (including any cold‑chain requirements), and necessary import documentation.

Modiodal (modafinil) is a first‑generation eugeroic, whereas armodafinil is its R‑enantiomer with a slightly longer half‑life. Both share similar efficacy, but individual response and tolerability can differ. Traditional stimulants such as methylphenidate act primarily on norepinephrine and dopamine reuptake and may have a higher risk of cardiovascular side effects.

Modiodal tablets should be stored at ambient temperature below 25 °C, in the original container, and protected from moisture and direct sunlight. Keep the product out of reach of children and do not use after the expiration date printed on the packaging.

Modiodal is taken orally, usually with a glass of water. It can be taken with or without food, but patients should follow the prescriber’s guidance regarding timing relative to meals to optimize tolerability and effectiveness.

Serious adverse events, although rare, include severe skin reactions such as Stevens‑Johnson syndrome, psychiatric disturbances (e.g., hallucinations, mania, depression), and cardiovascular complications like hypertension or arrhythmias. Patients should seek immediate medical attention if they experience rash, mood changes, chest pain, or palpitations.

Modiodal is contraindicated in individuals with known hypersensitivity to modafinil or any of its excipients. Caution is advised for patients with uncontrolled hypertension, significant cardiac disease, severe hepatic impairment, or a history of psychiatric disorders. Pregnant or breastfeeding women should only use it if the potential benefit outweighs the risk.